FDA Adverse Event Malfunction Summary report: N

COULTER LH 750 HEMATOLOGY ANALYZER

MDR report key: 2183618 · Received July 8, 2011

Report

Report Number
1061932-2011-00750
Event Type
Malfunction
Date Received
July 8, 2011
Date of Event
March 2, 2008
Report Date
March 6, 2008
Manufacturer
BECKMAN COULTER, INC.
Product Code
GKZ
PMA / PMN Number
K061574
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

CONTROLS WERE RUN 4 HOURS BEFORE THIS INCIDENT AND WERE WITHIN ACCEPTABLE RANGES. THE INSTRUMENT SENSITIVITY WAS SET AT 2202, WHICH IS MID-LEVEL FOR ALL BLAST FLAGS EXCEPT FOR IMM. NE 1 WHICH HAD BEEN TURNED OFF. NOTE: IMM NE 1 IS A FLAG FOR SUSPECT IMMATURE NEUTROPHILS, PRIMARILY BANDS. SERVICE DID NOT EVALUATE ANALYZER. ON (B)(6) 2008, A RECOMMENDATION WAS MADE TO ADD DEFINITE FLAG TO LY% (LYMPHOCYTE%). RAW DATA ANALYSIS WAS CONDUCTED AND DETERMINED THAT THE ALGORITHM FAILED TO FLAG THIS POPULATION WITH EITHER BLAST OR VARIANT LYMPH FLAG. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW CONDUCTED BETWEEN JANUARY 1, 2008 AND OCTOBER 23, 2010 OF COMPLAINTS FOR ADD'L REPORTABLE EVENTS. THIS MDR REPRESENTS EVENT 2 OF 2 REPORTED BY THIS CUSTOMER. THIS MDR IS RELATED TO THE FOLLOWING MDRS THAT HAVE BEEN REPORTED: MDR 1061932-2011-00749.

Description of Event or Problem · 1

CUSTOMER REPORTED ERRONEOUS DIFFERENTIAL TEST RESULTS WERE OBTAINED WHILE USING THE COULTER LH 750 HEMATOLOGY ANALYZER. THERE WERE NO INSTRUMENT GENERATED FLAGS FOR THESE TEST RESULTS. THE RESULTS WERE DETERMINED TO BE ERRONEOUS BASED ON A MANUAL DIFFERENTIAL WITH BLAST CELLS PRESENT. ERRONEOUS TEST RESULTS WERE NOT REPORTED OUTSIDE THE LAB. NO REPORTS OF DEATH OR SERIOUS INJURY, AND NO AFFECT TO PT TREATMENT AS A RESULT OF THIS EVENT. THIS EVENT REPRESENTS EVENT 2 OF 2 EVENTS REPORTED BY THIS CUSTOMER FOR THE SECOND OF TWO ANALYZERS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COULTER LH 750 HEMATOLOGY ANALYZER GKZ BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 20 MO